These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1590517)

  • 1. Elevated cortisol concentrations and the diminished prolactin response to fenfluramine.
    Mitchell PB; Smythe GA
    Am J Psychiatry; 1992 Jun; 149(6):851-2. PubMed ID: 1590517
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormonal responses to fenfluramine in depressive subtypes.
    Mitchell P; Smythe G; Parker G; Wilhelm K; Hickie I; Brodaty H; Boyce P
    Br J Psychiatry; 1990 Oct; 157():551-7. PubMed ID: 2131137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ; Murray RM; O'Keane V
    Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V; Dinan TG
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroendocrine response to fenfluramine in depressives and normal controls.
    Asnis GM; Eisenberg J; van Praag HM; Lemus CZ; Friedman JM; Miller AH
    Biol Psychiatry; 1988 May; 24(1):117-20. PubMed ID: 3370273
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormonal responses to fenfluramine in depressed and control subjects.
    Mitchell P; Smythe G
    J Affect Disord; 1990 May; 19(1):43-51. PubMed ID: 2140846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
    Lucey JV; O'Keane V; Butcher G; Clare AW; Dinan TG
    Br J Psychiatry; 1992 Oct; 161():517-21. PubMed ID: 1393339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patients.
    Weizman A; Mark M; Gil-Ad I; Tyano S; Laron Z
    Clin Neuropharmacol; 1988 Jun; 11(3):250-6. PubMed ID: 2969772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine challenges in the diagnosis of depressive disorders.
    López-Ibor JJ; Saiz-Ruiz J; Moral Iglesias L
    Br J Psychiatry Suppl; 1989 May; (4):73-6. PubMed ID: 2605013
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Endocrine responses to fenfluramine challenge in chronic fatigue syndrome.
    Cleare AJ; O'Keane V
    Can J Psychiatry; 1996 Mar; 41(2):129-31. PubMed ID: 8705960
    [No Abstract]   [Full Text] [Related]  

  • 11. Diminished prolactin responses to repeated fenfluramine challenge in man.
    Coccaro EF; Siever LJ; Klar H; Rubenstein K; Benjamin E; Davis KL
    Psychiatry Res; 1987 Nov; 22(3):257-9. PubMed ID: 3432453
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormone responses to fenfluramine and placebo challenge in endogenous depression.
    Lichtenberg P; Shapira B; Gillon D; Kindler S; Cooper TB; Newman ME; Lerer B
    Psychiatry Res; 1992 Aug; 43(2):137-46. PubMed ID: 1410069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin and cortisol responses to fenfluramine in Parkinson's disease.
    Kostić VS; Lecić D; Doder M; Marinković J; Filipović S
    Biol Psychiatry; 1996 Oct; 40(8):769-75. PubMed ID: 8894070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
    Maes M; Jacobs MP; Suy E; Minner B; Raus J
    Neuropsychobiology; 1989; 21(4):192-6. PubMed ID: 2561010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine.
    Park SB; Williamson DJ; Cowen PJ
    Psychol Med; 1996 Nov; 26(6):1191-6. PubMed ID: 8931165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects.
    Gorard DA; Taylor TM; Medbak SH; Perry LA; Libby GW; Farthing MJ
    Int Clin Psychopharmacol; 1993; 8(2):123-8. PubMed ID: 8393895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression.
    Thakore JH; Dinan TG
    Biol Psychiatry; 1995 Mar; 37(6):364-8. PubMed ID: 7772644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol and serotonin indices in depressed and suicidal patients.
    Sarchiapone M; Camardese G; Roy A; Della Casa S; Satta MA; Gonzalez B; Berman J; De Risio S
    J Affect Disord; 2001 Feb; 62(3):217-9. PubMed ID: 11223109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postdexamethasone prolactin and cortisol: a biological state variable in depression.
    Klein HE; Seibold B; Bender W; Nedopil N; Albus M; Schmauss M
    Acta Psychiatr Scand; 1984 Sep; 70(3):239-47. PubMed ID: 6496148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of anxiogenic vulnerability in panic disorder.
    Targum SD
    Psychiatry Res; 1990 Feb; 31(2):215-6. PubMed ID: 2326400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.